跳至主要内容
临床试验/NCT06045936
NCT06045936招募中4 期

Sciatic Block in Contralateral Limb for Treatment of Refractory Phantom and Residual Limb Pain; a Double-Blind Randomized Controlled Trial

Mayo Clinic1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2024年6月18日最近更新:
适应症
干预措施

试验速览

阶段
4 期
状态
招募中
发起方
Mayo Clinic
入组人数
20
试验地点
1
主要终点
Change in Functional Improvement

研究概览

简要总结

This research is being done to determine if an anesthetic like Lidocaine, may be effective when injected around the sciatic nerve of the intact limb in patients with limb loss pain on the contralateral side.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Lower extremity amputation performed more than 12 months before study enrollment
  • PLP/RLP in affected amputated limb > 4 on NRS26
  • Pain duration of more than 6 months despite a trial of conservative therapies for at least 2 months, including oral medications, topical medicines, physical therapy, and physical modalities (i.e., heat, cold, transcutaneous electrical nerve stimulation, phonophoresis)
  • Willingness to undergo image guided diagnostic nerve block

排除标准

  • Refusal / inability to participate or provide consent
  • Contraindications to diagnostic nerve block
  • Non-neurogenic source of PLP/RLP
  • Current opioid use > 50 morphine milligram equivalents per day
  • Any interventional pain treatment in the residual limb within the last 30 days
  • Severe uncontrolled medical condition (i.e., hypertensive crisis, decompensated hypothyroidism)
  • Use of investigational pain drug within past 30 days or other concurrent clinical trial enrollment

研究组 & 干预措施

Lidocaine Group

Experimental

Subjects will receive a lidocaine injection in the back of their residual limb.

干预措施: Lidocaine (Drug)

Sham Group

Placebo Comparator

Subjects will receive a placebo injection in the back of their residual limb.

干预措施: Placebo (Drug)

结局指标

主要结局

Change in Functional Improvement

时间窗: Baseline, 5 days post-injection

Measured using self-reported 20-item Orthotic and Prosthetics User's Survey (OPUS) Lower Extremity Functional Status Measurement survey. Total scores range from 0-100 scale with higher scores indicating a better outcome.

Change in pain

时间窗: Baseline, 60 minutes post injection

Measured using self-reported Numerical Rating Scale (NRS) where 0=no pain and 10=worst pain.

次要结局

  • Step Count(5 days post-injection)
  • Change in disability(Baseline, 5 days post-injection)
  • Change in Pressure-Pain Algometry(Baseline, 5 days post-injection)

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Cole W. Cheney

Principal Investigator

Mayo Clinic

研究点 (1)

Loading locations...

相似试验